Remarkably, even with less than 20% of frequency, the ACVR2A gene was discovered to be one of the driver genes and was significantly mutated among other genes, suggesting its possible role in tumorigenesis of CRC in our local patients. Here, ACVR2A is linked to colorectal carcinoma.